Vitamin K antagonist-experienced patients with a history of stroke/transient ischaemic attack who switched from warfarin to dabigatran increased their rate of recurrent stroke/transient ischaemic attack compared with those on warfarin.

Authors	John W Eikelboom, Jackie Bosch
Journal	Evidence-based medicine (Evid Based Med) Vol. 20 Issue 3 Pg. 117 (Jun 2015) ISSN: 1473-6810 [Electronic] England
PMID	25870161 (Publication Type: Journal Article, Comment)
Chemical References	Antithrombins Benzimidazoles beta-Alanine Warfarin
Topics	Antithrombins (therapeutic use) Atrial Fibrillation (drug therapy) Benzimidazoles (therapeutic use) Female Humans Ischemic Attack, Transient (prevention & control) Male Registries Stroke (prevention & control) Warfarin (therapeutic use) beta-Alanine (analogs & derivatives)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!